BioCentury | Feb 10, 2014
Finance

Confident roll of the dice(r)

...to $57.6M from $53.1M, but instrument revenues fell to $4M from $5.2M. Revenues from Affymetrix's eBioscience...
...which was acquired in June 2012, were $20.5M in 4Q13, up from $18.1M in 4Q12. eBioscience...
BioCentury | Nov 4, 2013
Finance

Calithera metabolizes

...were up less than 1% to $80.4M. The Street was expecting $79M. Revenues from Affymetrix's eBioscience...
...which was acquired in June 2012, were $19.9M in 3Q13, up from $17.6M in 3Q12. eBioscience...
BioCentury | Aug 5, 2013
Finance

Deciphering Dicerna's future

...from $66.4M in the prior year's quarter. The Street was expecting $78.5M. Revenues from Affymetrix's eBioscience...
...which was acquired in June 2012, were $18.8M in 2Q13, up from $1.4M in 2Q12. eBioscience...
BioCentury | Apr 10, 2013
Financial News

Affymetrix falls on preliminary 1Q13 results

...of $83.3 million. The microarray company, which expects about $19 million to come from its eBioscience...
BioCentury | Jan 14, 2013
Finance

Highlights of weekly biotech stock moves

...said it expects 4Q12 revenues of about $84 million, with $18 million coming from its eBioscience...
BioCentury | Jan 14, 2013
Company News

Affymetrix microarrays news

...expects 4Q12 revenues of about $84 million, with $18 million in revenues coming from its eBioscience...
BioCentury | Jan 9, 2013
Company News

Affymetrix previews 4Q12 figures, reducing headcount

...expects 4Q12 revenues of about $84 million, with $18 million in revenues coming from its eBioscience...
BioCentury | Oct 15, 2012
Analyst Picks & Changes

Analyst picks & changes

...be about $80M, below the Street's estimate of $84.6M. Affymetrix said its gene expression and eBioscience...
BioCentury | Oct 15, 2012
Finance

Highlights of weekly biotech stock moves

...$80 million, below the Street's estimate of $84.6 million. Affymetrix said its gene expression and eBioscience...
BioCentury | Oct 9, 2012
Financial News

Affymetrix slides on preliminary 3Q12 results

...$80 million, below the Street's estimate of $84.6 million. Affymetrix said its gene expression and eBioscience...
Items per page:
1 - 10 of 18
BioCentury | Feb 10, 2014
Finance

Confident roll of the dice(r)

...to $57.6M from $53.1M, but instrument revenues fell to $4M from $5.2M. Revenues from Affymetrix's eBioscience...
...which was acquired in June 2012, were $20.5M in 4Q13, up from $18.1M in 4Q12. eBioscience...
BioCentury | Nov 4, 2013
Finance

Calithera metabolizes

...were up less than 1% to $80.4M. The Street was expecting $79M. Revenues from Affymetrix's eBioscience...
...which was acquired in June 2012, were $19.9M in 3Q13, up from $17.6M in 3Q12. eBioscience...
BioCentury | Aug 5, 2013
Finance

Deciphering Dicerna's future

...from $66.4M in the prior year's quarter. The Street was expecting $78.5M. Revenues from Affymetrix's eBioscience...
...which was acquired in June 2012, were $18.8M in 2Q13, up from $1.4M in 2Q12. eBioscience...
BioCentury | Apr 10, 2013
Financial News

Affymetrix falls on preliminary 1Q13 results

...of $83.3 million. The microarray company, which expects about $19 million to come from its eBioscience...
BioCentury | Jan 14, 2013
Finance

Highlights of weekly biotech stock moves

...said it expects 4Q12 revenues of about $84 million, with $18 million coming from its eBioscience...
BioCentury | Jan 14, 2013
Company News

Affymetrix microarrays news

...expects 4Q12 revenues of about $84 million, with $18 million in revenues coming from its eBioscience...
BioCentury | Jan 9, 2013
Company News

Affymetrix previews 4Q12 figures, reducing headcount

...expects 4Q12 revenues of about $84 million, with $18 million in revenues coming from its eBioscience...
BioCentury | Oct 15, 2012
Analyst Picks & Changes

Analyst picks & changes

...be about $80M, below the Street's estimate of $84.6M. Affymetrix said its gene expression and eBioscience...
BioCentury | Oct 15, 2012
Finance

Highlights of weekly biotech stock moves

...$80 million, below the Street's estimate of $84.6 million. Affymetrix said its gene expression and eBioscience...
BioCentury | Oct 9, 2012
Financial News

Affymetrix slides on preliminary 3Q12 results

...$80 million, below the Street's estimate of $84.6 million. Affymetrix said its gene expression and eBioscience...
Items per page:
1 - 10 of 18